Tenax Therapeutics (TENX) Prepaid Assets (2011 - 2026)
Tenax Therapeutics (TENX) posted quarterly Prepaid Assets of $3.4 million for Q2 2026, up 764.56% year-over-year from $395000.0 in Q2 2025, and down 20.88% on a QoQ basis from $4.3 million in Q1 2026.
Tenax Therapeutics (TENX) Prepaid Assets (2011 - 2026) Analysis & Trends
Tenax Therapeutics has reported Prepaid Assets for 15 years, with the latest figure at $3.4 million in Q2 2026.
- Prepaid Assets for Q2 2026 came in at $3.4 million, up 764.56% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.4 million (up 764.56% YoY), and the FY2025 annual result was $5.6 million, up 218.63% from the prior year.
- Prepaid Assets fell to $3.4 million in Q2 2026, from $4.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $5.6 million in Q4 2025 and troughed at $362551.0 in Q2 2023.
- A 5-year average of $1.7 million and a median of $1.0 million in 2022 frame the typical range for Prepaid Assets.
- The widest annual swing landed in 2025, when Prepaid Assets sank 71.57%; it then surged 764.56% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $738927.0 in 2022, then soared by 121.94% to $1.6 million in 2023, then grew by 7.99% to $1.8 million in 2024, then soared by 218.63% to $5.6 million in 2025, then sank by 39.48% to $3.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $3.4 million in Q2 2026, $4.3 million in Q1 2026, and $5.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.42 Mn |
| Mar 31, 2026 | 4.32 Mn |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 395,000.00 |
| Mar 31, 2025 | 524,000.00 |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 33,875.00 |
| Jun 30, 2024 | 50,250.00 |
| Mar 31, 2024 | 66,625.00 |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 474,866.00 |
| Jun 30, 2023 | 282,583.00 |
| Mar 31, 2023 | 304,583.00 |
| Dec 31, 2022 | 345,856.00 |
| Sep 30, 2022 | 707,194.00 |
| Jun 30, 2022 | 872,363.00 |
| Mar 31, 2022 | 586,987.00 |
| Sep 30, 2021 | 229,152.00 |
| Jun 30, 2021 | 349,862.00 |